Literature DB >> 20665538

Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes.

M C Arufe1, A De la Fuente, I Fuentes, F J de Toro, F J Blanco.   

Abstract

In this study we analyzed the chondrogenic potential of subpopulations of mesenchymal stem cells (MSCs) derived from human synovial membranes enriched for CD73, CD106, and CD271 markers. Subpopulations of human synovial membrane MSCs enriched for CD73, CD106, and CD271 markers were isolated using a cytometry sorter and characterized by flow cytometry for MSC markers. The expression of Sox9, Nanog, and Runx2 genes by these cells was measured by reverse transcriptase-polymerase chain reaction. The chondrogenesis of each subpopulation was assessed by culturing the cells in a defined medium to produce spontaneous spheroid formation and differentiation towards chondrocyte-like cells. The examination of the spheroids by histological and immunohistochemical analyses for collagen type II (COL2), aggrecan, collagen type I (COL1), metalloprotease 13 (MMP13), and collagen type X (COLX) levels were performed to assess their chondrogenesis capacity. The adipogenesis and osteogenesis potential of each subpopulation was determined using commercial media; the resulting cells were stained with oil red O or red alizarin to test the degree of differentiation. The subpopulations had different profiles of cells positive for the MSC markers CD44, CD69, CD73, CD90, and CD105 and showed different expression levels of the genes Sox9, Nanog, and Runx2 involved in chondrogenesis, undifferentiation, and osteoblastogenesis, respectively. Immunohistochemical analysis demonstrated that COL1, COL2, COLX, MMP13, and aggrecan were expressed in the spheroids as soon as 14 days of culture. The CD271(+) subpopulation expressed the highest levels of COL2 staining compared to the other subpopulations. CD105 and Runx2 were shown by immunohistochemistry and genetic analysis to have significantly higher expression CD271(+) subpopulation than the other subpopulations. Spheroids formed from CD271-enriched and CD73-enriched MSCs from normal human synovial membranes mimic the native cartilage extracellular matrix more closely than CD106(+) MSCs and are possible candidates for use in cartilage tissue engineering. Both cell types have potential for promoting the differentiation of MSCs into chondrocytes, presenting new possibilities for achieving intrinsic cartilage repair.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665538     DOI: 10.1002/jcb.22768

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  36 in total

1.  The effects of hypoxia and serum-free conditions on the stemness properties of human adipose-derived stem cells.

Authors:  Wan Kamarul Zaman Wan Safwani; Chin Wei Wong; Kar Wey Yong; Jane Ru Choi; Noor Azmi Mat Adenan; Siti Zawiah Omar; Wan Abu Bakar Wan Abas; Belinda Pingguan-Murphy
Journal:  Cytotechnology       Date:  2016-01-04       Impact factor: 2.058

2.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.

Authors:  Jessica L Lo Surdo; Bryan A Millis; Steven R Bauer
Journal:  Cytotherapy       Date:  2013-08-29       Impact factor: 5.414

3.  Role of Suppressor of Cytokine Signaling 3 in the Immune Modulation of Mesenchymal Stromal Cells.

Authors:  Chen Yang; Chunquan Zheng; Hai Lin; Jing Li; Keqing Zhao
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Time-dependent processes in stem cell-based tissue engineering of articular cartilage.

Authors:  Ivana Gadjanski; Kara Spiller; Gordana Vunjak-Novakovic
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

5.  Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor β1 (TGFβ1) signaling.

Authors:  Jennifer Velasco; Jun Li; Luisa DiPietro; Mary Ann Stepp; John D Sandy; Anna Plaas
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.

Authors:  Syed Amir Iqbal; Christopher Manning; Farhatullah Syed; Venkatesh Kolluru; Mike Hayton; Stewart Watson; Ardeshir Bayat
Journal:  Stem Cells Dev       Date:  2011-07-19       Impact factor: 3.272

7.  Isolation and Cellular Phenotyping of Mesenchymal Stem Cells Derived from Synovial Fluid and Bone Marrow of Minipigs.

Authors:  Won-Jae Lee; Ji-Sung Park; Si-Jung Jang; Seung-Chan Lee; HyeonJeong Lee; Jae-Hoon Lee; Gyu-Jin Rho; Sung-Lim Lee
Journal:  J Vis Exp       Date:  2016-07-02       Impact factor: 1.355

Review 8.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Authors:  Miaohua Mo; Shan Wang; Ying Zhou; Hong Li; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

9.  Induction of re-differentiation of passaged rat chondrocytes using a naturally obtained extracellular matrix microenvironment.

Authors:  Myung Hwa Cha; Sun Hee Do; Ga Ram Park; Ping Du; Ki-Chul Han; Dong Keun Han; Kwideok Park
Journal:  Tissue Eng Part A       Date:  2013-01-05       Impact factor: 3.845

10.  Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.

Authors:  Romain Contentin; Magali Demoor; Miranda Concari; Mélanie Desancé; Fabrice Audigié; Thomas Branly; Philippe Galéra
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.